JDSC株式会社は、大鵬薬品工業株式会社、株式会社ビジネスエンジニアリングと共同で、医薬品の製造工程を高度化するスマートファクトリープロジェクトを立ち上げました。
このプロジェクトの主な目的は、工程の安定化、業務効率の改善、生産能力の拡大です。次世代製造実行システム(MES)の導入と製造記録のデジタル化により、リアルタイム・モニタリングと自動工程管理を設計・実施します。
長年にわたって 大鵬薬品工業 has implemented many reforms to ensure the quality and stable supply of pharmaceuticals, including enhancing compliance with GMP (standards for manufacturing and quality control of pharmaceuticals), on-site improvement activities, and converting paper records to electronic records. This latest initiative is an evolution that builds on this history and track record, and aims to build a smart factory that combines “human wisdom” and “digital technology” while leveraging the knowledge cultivated on-site.
こちらもお読みください: AI創薬プラットフォーム「Elix DiscoveryTM」を杏林製薬に提供
このプロジェクトは B-EN-G‘s MES solution, which has a proven track record in the pharmaceutical industry, with JDSC’s process design and optimization know-how centered on AI and data analysis. Through this collaboration, the two companies will not only implement the system, but will also provide consistent support for data integrity and GMP-compliant operational design.
The shortage of skilled personnel in pharmaceutical manufacturing and the dependency on paperwork are structural issues in Japan’s pharmaceutical supply. This project serves as a model case for overcoming these challenges through the power of technology, with a view to introducing it to multiple locations and expanding it to the entire industry, contributing to the upgrading of Japan that ジェーディーエスシー を達成することを目指しています。
ソース PRタイムズ
